Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy
Marion V. Guérin(Inserm), Philippe Bousso(Inserm), Pierre Guermonprez(Institut Pasteur), Bruno Iannascoli(Inserm), Capucine L. Grandjean(Inserm), Béatrice Corre(Inserm), Fabrice Lemaı̂tre(Inserm), Mathilde Ruggiu(Inserm), Pauline Ombredanne(Inserm), Lynn Macdonald(Regeneron (United States)), Pierre Bruhns(Inserm), Lea C Feldmann(Inserm), Zacarias Garcia(Inserm)
Cited by 1
Related Papers
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
|Blood|2008|1.5k
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
|Proceedings of the National Academy of Sciences|2018|948